Home / Candesartan / Germany
DE ATC C09CA06 · updated 2 Nov 2026
Candesartan shortage in Germany
Is there a Candesartan shortage in Germany?
Yes. As of 2 Nov 2026, 13 Candesartan products are reported short in Germany, the first since 11 Feb 2025. The company estimate for the return is 31 Dec 2026 (latest 5 Oct 2028). Main reason: active ingredient shortage.
Also short in Canada, Italy, Spain, Austria, Czechia, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | CANDESARTAN BASICS 4 mg Tabletten | Basics GmbH | 11 Feb 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 4 mg Tabletten | Basics GmbH | 11 Feb 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 4 mg Tabletten | Basics GmbH | 11 Feb 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | Blopress 16 mg | Cheplapharm Arzneimittel GmbH | 6 Oct 2025 | 5 Oct 2028 | Other Sonstige |
| DE | CANDESARTAN BASICS 16 mg Tabletten | Basics GmbH | 20 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 16 mg Tabletten | Basics GmbH | 20 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 16 mg Tabletten | Basics GmbH | 20 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 8 mg Tabletten | Basics GmbH | 22 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 8 mg Tabletten | Basics GmbH | 22 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 8 mg Tabletten | Basics GmbH | 22 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 32 mg Tabletten | Basics GmbH | 24 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 32 mg Tabletten | Basics GmbH | 24 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | CANDESARTAN BASICS 32 mg Tabletten | Basics GmbH | 24 Nov 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.